BIO ENDORSES NOMINATION OF VON ESCHENBACH TO HEAD FDA

Jim Greenwood, president and CEO of the Biotechnology Industry Organization (BIO), released a statement encouraging the U.S. Senate to swiftly confirm Dr. Andrew von Eschenbach as commissioner of the Food and Drug Administration (FDA).
PR Newswire